194 related articles for article (PubMed ID: 10612710)
21. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
22. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
Bifulco M; Laezza C; Portella G; Vitale M; Orlando P; De Petrocellis L; Di Marzo V
FASEB J; 2001 Dec; 15(14):2745-7. PubMed ID: 11687506
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
Androvicova R; Horacek J; Stark T; Drago F; Micale V
Pharmacol Res; 2017 Jan; 115():200-208. PubMed ID: 27884725
[TBL] [Abstract][Full Text] [Related]
25. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.
López-Moreno JA; López-Jiménez A; Gorriti MA; de Fonseca FR
Curr Drug Targets; 2010 Apr; 11(4):406-28. PubMed ID: 20196742
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells.
Puffenbarger RA; Boothe AC; Cabral GA
Glia; 2000 Jan; 29(1):58-69. PubMed ID: 10594923
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
Tanda G; Goldberg SR
Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
[TBL] [Abstract][Full Text] [Related]
28. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Cox ML; Welch SP
Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
[TBL] [Abstract][Full Text] [Related]
29. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
[TBL] [Abstract][Full Text] [Related]
30. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors.
Hejazi N; Zhou C; Oz M; Sun H; Ye JH; Zhang L
Mol Pharmacol; 2006 Mar; 69(3):991-7. PubMed ID: 16332990
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
Hasanein P
Neurosci Lett; 2009 Oct; 462(3):230-4. PubMed ID: 19616063
[TBL] [Abstract][Full Text] [Related]
32. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
33. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
34. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
35. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
36. The neurobiology of cannabinoid dependence: sex differences and potential interactions between cannabinoid and opioid systems.
Ambrosio E; Martín S; García-Lecumberri C; Crespo JA
Life Sci; 1999; 65(6-7):687-94. PubMed ID: 10462069
[TBL] [Abstract][Full Text] [Related]
37. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine.
Viganò D; Valenti M; Cascio MG; Di Marzo V; Parolaro D; Rubino T
Eur J Neurosci; 2004 Oct; 20(7):1849-57. PubMed ID: 15380006
[TBL] [Abstract][Full Text] [Related]
38. The Role of the Cannabinoid System in Opioid Analgesia and Tolerance.
Ozdemir E
Mini Rev Med Chem; 2020; 20(10):875-885. PubMed ID: 32167427
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
40. Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.
Viganò D; Grazia Cascio M; Rubino T; Fezza F; Vaccani A; Di Marzo V; Parolaro D
Neuropsychopharmacology; 2003 Jun; 28(6):1160-7. PubMed ID: 12637958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
